We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

47 hedge funds and large institutions have $52.1M invested in Eterna Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 4

105% more call options, than puts

Call options by funds: $638K | Put options by funds: $311K

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

10% more capital invested

Capital invested by funds: $47.3M → $52.1M (+$4.74M)

7% more funds holding

Funds holding: 44 → 47 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
18
Reduced
4
Closed
8
Calls
$638K
Puts
$311K
Net Calls
+$327K
Net Calls Change
-$129K

Top Buyers

Rank Fund Capital Flow
1
CPWM
Cypress Point Wealth Management
Texas
+$10.3M
2
IC
Inverness Counsel
New York
+$8.65M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.55M
4
JP Morgan Chase
JP Morgan Chase
New York
+$4.19M
5
Morgan Stanley
Morgan Stanley
New York
+$3.92M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$1.22M
2
Voloridge Investment Management
Voloridge Investment Management
Florida
-$453K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$191K
4
Simplex Trading
Simplex Trading
Illinois
-$163K
5
Ameriprise
Ameriprise
Minnesota
-$110K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWP
26
Baldwin Wealth Partners
Massachusetts
$161K – – –
Jane Street
27
Jane Street
New York
$145K +$163K +3 +150%
Marshall Wace
28
Marshall Wace
United Kingdom
$138K +$218K +4 New
Two Sigma Advisers
29
Two Sigma Advisers
New York
$94K +$163K +3 New
Millennium Management
30
Millennium Management
New York
$85K – – –
Deutsche Bank
31
Deutsche Bank
Germany
$79K +$54.4K +1 +50%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$74K – – –
UBS Group
33
UBS Group
Switzerland
$68K +$54.4K +1 +100%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$67K – – –
AIG
35
American International Group
New York
$66K – – –
JF
36
Jump Financial
Illinois
$65K +$109K +2 New
State Board of Administration of Florida Retirement System
37
State Board of Administration of Florida Retirement System
Florida
$63K – – –
ProShare Advisors
38
ProShare Advisors
Maryland
$58K +$109K +2 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$53K – – –
AFG
40
Allegheny Financial Group
Pennsylvania
$48K – – –
Invesco
41
Invesco
Georgia
$46K -$54.4K -1 -50%
VOYA Investment Management
42
VOYA Investment Management
Georgia
$44K -$54.4K -1 -50%
Citigroup
43
Citigroup
New York
$39K +$54.4K +1 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$28K – – –
SO
45
STRS Ohio
Ohio
$28K – – –
Simplex Trading
46
Simplex Trading
Illinois
$27K -$163K -3 -75%
Legal & General Group
47
Legal & General Group
United Kingdom
$13K – – –
TRCT
48
Tower Research Capital (TRC)
New York
$12K – – –
Group One Trading
49
Group One Trading
Illinois
$11K – – –
AIP
50
Ameritas Investment Partners
Nebraska
$8K – – –
1
2
3

ERNA Hedge Fund Activity: Q4 2021 in Review

47 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2021, worth a combined $52.1M — up 10% from $47.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ERNA positions and 8 closed out — a net gain of 3 holders — while 18 added to existing stakes and 4 trimmed.

The largest buyer was Cypress Point Wealth Management, adding an estimated $10.3M. The largest seller was Eagle Asset Management, exiting entirely with an estimated $1.22M sold.

  • 47 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2021, up from 44 in Q3 2021.
  • Funds reported $52.1M of Eterna Therapeutics stock for Q4 2021, up 10% quarter-over-quarter.
  • 11 funds opened new Eterna Therapeutics positions in Q4 2021 and 8 closed out, a net change of +3 holders.
  • The largest Eterna Therapeutics buyer in Q4 2021 was Cypress Point Wealth Management, an estimated $10.3M added.
  • The largest Eterna Therapeutics seller in Q4 2021 was Eagle Asset Management, an estimated $1.22M sold.

Based on aggregated 13F filings for Q4 2021.